S1764

Complement sera human

lyophilized powder

• Synonym(s): Human Serum Complement
• MDL number: MFCD00130855
• UNSPSC Code: 12352202
• NACRES: NA.61

Properties

• biological source: human
• Quality Level: 200
• form: lyophilized powder
• origin: USA origin
• technique(s): cell culture | mammalian: suitable
• impurities: virus, tested
• shipped in: dry ice
• storage temp.: −20°C

Description

General description

Complement serum is prepared from pooled human plasma and lyophilized from the amount of serum indicated on the label.

Application

Complement sera human has been used:

• to incubate DLD-1 or SW-620 cells to quantify C5a release
• in multiplex bead antibody-binding assay to assay C3d
• in complement-dependent cytotoxicity assay

Complement sera human has been used:

• to incubate DLD-1 or SW-620 cells to quantify C5a release
• in multiplex bead antibody-binding assay to assay C3d
• in complement-dependent cytotoxicity assay

The activity of complement sera can be determined by hemolytic assays in vitro.

Physical form

Lyophilized powder from indicated amount of serum

Analysis Note

Hemolytic titer (CH₅₀ units per ml) is determined by method of Kabat and Mayer. Actual titer given on label.

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Safety Information

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable